BioZorb Breast Marker Lawsuit Filings
Stay up to date on the BioZorb Breast Marker Lawsuit and pending MDL proceedings. This page provides official court filings, Pretrial Orders (PTOs), and Case Management Orders (CMOs) related to claims that the BioZorb surgical marker caused chronic pain, infections, and disfigurement after breast surgery. Check back regularly for updates as the BioZorb lawsuits progress toward federal consolidation and coordinated discovery.
Camp Lejeune Cancer Claims
NGRV is no longer accepting new clients for Camp Lejeune Lawsuit Learn More Camp Lejeune Lawsuit Located in Onslow County, southeastern North Carolina, you will find Marine Corps Base Camp Lejeune. Taking a prominent space in the military town of Jacksonville, the base sits adjacent to the New River flowing to the Onslow Beach area, […]
Exactech Equinoxe Shoulder System Recall Lawsuit
The Exactech Equinoxe Shoulder System was designed to offer patients improved joint stability and range of motion, this system gained popularity in the orthopedic community. However, in August 2021, the FDA issued a warning about the shoulder system. The reason cited was a critical defect in the packaging, which potentially compromised the sterility and integrity […]
Genesis Bankruptcy Lawsuit
Genesis Bankruptcy Lawsuit Let’s dive into the Genesis Bankruptcy lawsuit: Genesis Global Capital, the cryptocurrency lending arm of Digital Currency Group (DCG), suspended customer withdrawals in November of 2022. Genesis issued billions of dollars in loans in the year 2021 and funded those loans from individuals and institutions that owned large quantities of coins. There […]
FTX Bankruptcy Lawsuit
FTX Lawsuit The FTX crypto exchange was co-founded by the now infamous Sam Bankman-Fried (also referred to as SBF), who has been accused of massive fraud, conspiracy, and violating campaign finance laws. FTX, a multibillion-dollar company, was among the largest crypto exchanges in the world. FTX declaring bankruptcy has resulted in hundreds of thousands of retail […]
